All In MedTech

Company

Medivance

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Latest round: equity, $8.1M raised of $11.8M sought, first sale Jun 25, 2009, 17 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Jun 25, 2009Equity$8.1M$11.8M17Rule 506Form D ↗Jul 9, 2009

Company details

From the company's latest Form D.

Legal name
MEDIVANCE INC
Headquarters
Louisville, CO
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    10 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Medivance.

    Latest FDA decisions

    Search the Clearance Tracker

    4 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 23264200
    Jan 24280300
    Feb 24328310
    Mar 24232400
    Apr 24260300
    May 24300300
    Jun 24178300
    Jul 24240400
    Aug 24261100
    Sep 24365300
    Oct 24221200
    Nov 24200200
    Dec 24218200
    Jan 25246100
    Feb 25208300
    Mar 25193200
    Apr 25184200
    May 25196100
    Jun 25193200
    Jul 25211300
    Aug 25188300
    Sep 25193000
    Oct 25173100
    Nov 25136200
    Dec 25162000
    Jan 26129000
    Feb 26182300
    Mar 26146600
    Apr 26147100
    May 26104400
    Jun 26102200
    Jul 261661600
    Aug 26107100
    Sep 2681300
    Oct 2699100
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    The full in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    2 more recall records with a free account

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.